← brief for 2026-08-13 · Slowing decline

SGLT2 Inhibitors in Type 1 Diabetes: The Metabolic Perspective.

Article A Peer reviewed Meta-analysis or large trial

Key takeaways

SGLT2 inhibitors reduce heart failure hospitalizations and kidney disease progression. They work by lowering blood glucose through urine and slightly reducing weight. This group of drugs is used for diabetes and heart failure patients.

Who did this work

Hamidi V · Mudaliar S

Source

Article · PubMed, the drug frontier · 2026 Aug 13
https://pubmed.ncbi.nlm.nih.gov/42587088/